Board of Trustees
The Board of Trustees of the Max Planck Institute for Molecular Genetics supports the Institute and fosters connections between the MPIMG and the public. The members of the Board of Trustees are appointed by the president of the Max Planck Society. They meet regularly at the Institute to stay informed about its work and general development. The Board of Trustees is formed by representatives from the local politics, industry, science, and the media.
Members of the Board of Trustees (appointment period 2014 - 2019)
Prof. Dr. Erwin Böttinger
Vorsitzender des Vorstands
Berlin Institute of Health (BIH), Berlin
Prof. Dr. Andreas E. Busch
Head of Global Drug Discovery
Bayer HealthCare Pharmaceutical, Berlin
Prof. Dr. Karl Max Einhäupl
Chairman of the Executive Board
Charité - Universitätsmedizin Berlin
Prof. Dr. Peter A. Frensch
Vice President for Research
Humboldt-Universität zu Berlin
Prof. Dr. Detlev Ganten
Chairman of the Foundation Board
Charité Foundation, Berlin
Prof. Dr. Monika Schäfer-Korting
Vice President of the
Freie Universität Berlin
Prof. Dr. Karl Sperling
Institute of Human Genetics
Charité - Universitätsmedizin Berlin
Prof. Dr. Günter Stock
President of the
Berlin-Brandenburgischen Academy of Sciences and Humanities, Berlin
Dr. Hartmut Wewetzer
Science editor
Der Tagesspiegel, Berlin
